Hepatitis C and HIV

Unfortunately a high percentage of those affected with HIV are also infected with the Hepatitis C virus. It is believed that nearly forty percent of HIV sufferers also have HCV.  This is because both viruses are transmitted the same way. They can be passed along by the shared use of needles or other drug paraphernalia or by unprotected sex because they are both transferred by blood-to-blood transmissions.   This means that it is not a surprise that people will be coinfected, having both infections, but it definitely makes treating them more difficult. Especially since Hepatitis C., also known as HCV, makes HIV worse, though it is known that it does not interfere with the medications used to treat HIV.

Studies conducted on people who are coinfected have found that this group seems to suffer a higher proportion of cases of depression, not a surprise when you think of what they have to deal with in their lives. The concern is that those who are feeling this way may be more apt to mix up their medications or even forget to take them.

One of the most difficult treatment issues with someone who is coinfected can be which should be treated first the HIV or the HCV? This must be decided based on severity and the progress of each infection. If the Hepatitis C is showing only mild symptoms then the HIV should be treated first. Leaving HIV untreated for six months to a year could be very hard on the patient's body and could lead to further complications down the way. On the other hand if the cell counts are high enough and the HCV is problematic then treating the hepatitis would be helpful in the long run. This is especially true because the liver will then be able to deal better with the strong drugs that need to be taken for HIV.

Those who are coinfected are at risk for the Hepatitis C virus to be much worse than others who are fighting only the one virus. With both, the patient may find that serious liver disease progresses much faster. Liver failure can actually occur.  Drug therapy for those who are coinfected is successful twenty five to fifty percent of the time depending on which genotype the HCV is. The results are better with type two and three then type one.  The drugs that are necessary to treat HIV can be very hard on the liver and so make for one more reason that trying to treat the HCV is very important.

When someone is coinfected the viral levels of the hepatitis are much higher. This means that the spread of the infection becomes that much easier and so the patient must work harder to control this potential for spreading. Do not share anything that may have even the minutest amount of blood on it. That includes toothbrushes, facecloths or razors.
If you're coinfected, or someone you love is, be sure the physician is able to treat you for both these difficult viruses.

Hepatitis news on the Web

Hepatitis C sufferers tell how 'manky' blood devastated their lives SCOTTISH patients infected with hepatitis C or HIV through blood products have revealed the devastating impact on their lives as the first stage of a major inquiry ended.

Hepatitis C Spikes Among Young Heroin Users The Department of Public Health says infection rates for Hepatitis C in 15- to 25-year-olds have almost doubled since 2002. But there’s no money in this year’s budget for Hep C prevention or to treat new patients.

Vertex hepatitis C drug helps the hard-to-treat CAMBRIDGE -- Vertex Pharmaceuticals Inc. said Tuesday that a late-stage clinical trial showed its hepatitis C drug candidate telaprevir proved effective for patients who hadn't been helped by other treatments. Vertex Pharmaceuticals - Clinical trial - Telaprevir - Hepatitis C - Drug

For biotechs, no easy task Hepatitis C, a serious medical problem around the world, is also one of the most important disease targets for the state's biotechnology industry. Hepatitis C - Biotechnology - Hepatitis - Business - Health

12-16 mln Vietnamese infected with Hepatitis B The Vietnam Association for the Study of Liver Disease recently estimated that 15 to 20 percent of Vietnam’s population (12 to 16 million people) is infected with the hepatitis B virus (HBV).

60% Rise In Deaths From Liver Disease In Last Decade: Hepatitis C Is An Increasing Contributor Huge variations in hepatitis C services in hospitals across the country are revealed in a new report by the All-Party Parliamentary Hepatology Group and The Hepatitis C Trust. In The Dark found widely differing policies on who should receive treatment and the level of specialist support and care available. Hepatitis C is a preventable and treatable blood-borne virus. It is estimated that between ...

Quiz: Your Hepatitis C Knowledge Test your knowledge of Hepatitis C with our quiz.

Vertex, J&J Hepatitis C Drug Works After Others Fail Vertex Pharmaceuticals Inc .’s most advanced experimental drug, in development with Johnson & Johnson, worked in patients with hepatitis C who didn’t respond to other treatment, a study found.

Biotech Busts And Breakthroughs The competition for new hepatitis C drugs is heating up. Wall Street is already picking winners.

Bristol-Myers Buys Hepatitis Partner for $885 Million Bristol-Myers Squibb Co. said it plans to buy ZymoGenetics Inc. for $885 million to gain full ownership of a hepatitis C drug the companies are developing.